BioXcel Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
BioXcel Therapeutics, Inc. (BTAI) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 27.97 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-10
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 27.97M shares, a 21.35% increase year-over-year.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 24.96M shares, a 23.01% increase year-over-year.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 24.52M shares, a 29.29% increase year-over-year.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 24.39M shares, a 35.00% increase year-over-year.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 21.68M shares, a 33.11% increase from fiscal 2019.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 16.29M shares, a 11.79% increase from fiscal 2018.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 14.57M shares, a 50.45% increase from fiscal 2017.
- BioXcel Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 9.69M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | 27.97M shares 10-Q · filed 2021-11-10 | 26.47M shares derived: average of 2 quarters · filed 2021-11-10 | 25.83M shares 10-Q · filed 2021-11-10 | 25.46M shares derived: average of 4 quarters · filed 2021-11-10 | ||||
| 2021-06-30 | 24.96M shares 10-Q · filed 2021-08-10 | 24.74M shares 10-Q · filed 2021-08-10 | 24.63M shares derived: average of 3 quarters · filed 2021-08-10 | 24.23M shares derived: average of 4 quarters · filed 2021-11-10 | ||||
| 2021-03-31 | 24.52M shares 10-Q · filed 2021-05-10 | 24.46M shares derived: average of 2 quarters · filed 2021-05-10 | 23.99M shares derived: average of 3 quarters · filed 2021-11-10 | 23.07M shares derived: average of 4 quarters · filed 2021-11-10 | ||||
| 2020-12-31 | 24.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 23.72M shares derived: average of 2 quarters · filed 2021-11-10 | 22.58M shares derived: average of 3 quarters · filed 2021-11-10 | 21.68M shares 10-K · filed 2021-03-12 | ||||
| 2020-09-30 | 23.05M shares 10-Q · filed 2021-11-10 | 23.05M shares 10-Q · filed 2020-11-12 | 21.67M shares derived: average of 2 quarters · filed 2021-11-10 | 20.78M shares 10-Q · filed 2021-11-10 | 20.78M shares 10-Q · filed 2020-11-12 | 20.10M shares derived: average of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | 20.29M shares 10-Q · filed 2021-08-10 | 20.29M shares 10-Q · filed 2020-08-14 | 19.62M shares 10-Q · filed 2021-08-10 | 19.62M shares 10-Q · filed 2020-08-14 | 19.11M shares derived: average of 3 quarters · filed 2021-08-10 | 18.27M shares derived: average of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | 18.97M shares 10-Q · filed 2021-05-10 | 18.97M shares 10-Q · filed 2020-05-12 | 18.52M shares derived: average of 2 quarters · filed 2021-05-10 | 17.60M shares derived: average of 3 quarters · filed 2021-05-10 | 17.11M shares derived: average of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | 18.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 16.91M shares derived: average of 2 quarters · filed 2021-03-12 | 16.50M shares derived: average of 3 quarters · filed 2021-03-12 | 16.29M shares 10-K · filed 2021-03-12 | 16.29M shares 10-K · filed 2020-03-09 | |||
| 2019-09-30 | 15.75M shares 10-Q · filed 2020-11-12 | 15.71M shares derived: average of 2 quarters · filed 2020-11-12 | 15.70M shares 10-Q · filed 2020-11-12 | 15.67M shares derived: average of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | 15.67M shares 10-Q · filed 2020-08-14 | 15.67M shares 10-Q · filed 2020-08-14 | 15.64M shares derived: average of 3 quarters · filed 2020-08-14 | 15.64M shares derived: average of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | 15.66M shares 10-Q · filed 2020-05-12 | 15.63M shares derived: average of 2 quarters · filed 2020-05-12 | 15.64M shares derived: average of 3 quarters · filed 2020-05-12 | 15.64M shares derived: average of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | 15.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 15.62M shares derived: average of 2 quarters · filed 2020-03-09 | 15.63M shares derived: average of 3 quarters · filed 2020-03-09 | 14.57M shares 10-K · filed 2020-03-09 | ||||
| 2018-09-30 | 15.65M shares 10-Q · filed 2019-11-14 | 15.65M shares derived: average of 2 quarters · filed 2019-11-14 | 14.23M shares 10-Q · filed 2019-11-14 | 13.26M shares derived: average of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | 15.65M shares 10-Q · filed 2019-08-06 | 13.51M shares 10-Q · filed 2019-08-06 | 12.46M shares derived: average of 3 quarters · filed 2019-08-06 | 11.72M shares derived: average of 4 quarters · filed 2019-08-06 | ||||
| 2018-03-31 | 11.46M shares 10-Q · filed 2019-05-07 | 10.87M shares derived: average of 2 quarters · filed 2019-05-07 | 10.41M shares derived: average of 3 quarters · filed 2019-05-07 | 10.18M shares derived: average of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | 10.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 9.89M shares derived: average of 2 quarters · filed 2019-03-12 | 9.75M shares derived: average of 3 quarters · filed 2019-03-12 | 9.69M shares 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | 9.48M shares 10-Q · filed 2018-11-09 | 9.48M shares derived: average of 2 quarters · filed 2018-11-09 | 9.48M shares 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | 9.48M shares 10-Q · filed 2018-08-08 | 9.48M shares 10-Q · filed 2018-08-08 | ||||||
| 2017-03-31 | 9.48M shares 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |